©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8193-8199
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8193
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8193
Table 1 Clinicopathologic characteristics n (%)
| Characteristics | |
| Mean 64.9 yr (range 40-83) | |
| Gender | |
| Male | 114 (82) |
| Female | 25 (18) |
| Tumor location | |
| Middle 1/3 of esophagus | 11 (8) |
| Lower 1/3 of esophagus and GEJ | 128 (92) |
| Tumor histology | |
| Adenocarcinoma | 129 (92.8) |
| Squamous cell carcinoma | 10 (7.2) |
| Clinical stage | |
| T1N0 | 110 (79.1) |
| T2N0 | 29 (20.9) |
| Type of esophagectomy | |
| Three-field | 2 (1.4) |
| Transhiatal | 26 (18.7) |
| Ivor-Lewis | 111 (79.9) |
| Adjuvant therapy | |
| Chemotherapy | 6 (4.3) |
| Chemoradiation | 3 (2.2) |
| None | 130 (93.5) |
- Citation: Luu C, Amaral M, Klapman J, Harris C, Almhanna K, Hoffe S, Frakes J, Pimiento JM, Fontaine JP. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation? World J Gastroenterol 2017; 23(46): 8193-8199
- URL: https://www.wjgnet.com/1007-9327/full/v23/i46/8193.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i46.8193